A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD
Clinical trial NCT05138250 · COMPLETED
Trial details
- NCT number
- NCT05138250
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-08
- Primary completion
- 2025-05-08
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.